Development and validation of a simple, selective, and sensitive LC-MS/MS assay for the quantification of remdesivir in human plasma

Remdesivir, formerly GS-5734, has recently become the first antiviral drug approved by the U.S. Food and Drug Administration (FDA) to treat COVID-19, the disease caused by SARS-CoV-2. Therapeutic dosing and pharmacokinetic studies require a simple, sensitive, and selective validated assay to quantif...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Chromatogr B Analyt Technol Biomed Life Sci
Autori principali: Nguyen, Ryan, Goodell, Jennifer C., Shankarappa, Priya S., Zimmerman, Sara, Yin, Tyler, Peer, Cody J., Figg, William D.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2021
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7944857/
https://ncbi.nlm.nih.gov/pubmed/33756448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jchromb.2021.122641
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi